Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1859618
Reference Type
Journal Article
Title
QF-PCR as a substitute for karyotyping of cytotrophoblast for the analysis of chorionic villi: advantages and limitations from a cytogenetic retrospective audit of 44,727 first-trimester prenatal diagnoses
Author(s)
Grati, FR; Malvestiti, F; Grimi, B; Gaetani, E; Di Meco, AM; Trotta, A; Liuti, R; Chinetti, S; Dulcetti, F; Ruggeri, AM; Agrati, C; Frascoli, G; Milani, S; De Toffol, S; Martinoni, L; Paganini, S; Marcato, L; Maggi, F; Simoni, G
Year
2013
Is Peer Reviewed?
1
Journal
Prenatal Diagnosis
ISSN:
0197-3851
EISSN:
1097-0223
Volume
33
Issue
5
Page Numbers
502-508
Language
English
PMID
23606546
DOI
10.1002/pd.4099
Web of Science Id
WOS:000318440000015
Abstract
OBJECTIVES:
Karyotyping on chorionic villous samples (CVS) includes the analysis of both cytotrophoblast (STC) and mesenchyme (LTC). This approach requires complex laboratory organization and trained technicians. The introduction of quantitative fluorescent polymerase chain reaction (QF-PCR) instead of conventional karyotyping in low-risk pregnancies opened its application in CVS analysis. Discordant QF-PCR and CVS cytogenetic results were reported, and strategies for CVS analysis were introduced to minimize this risk. The possibility to substitute the STC with QF-PCR was reported. The aim of this study is to evaluate benefits and limitations of the approach QF-PCR + LTC compared with the traditional method STC + LTC and to quantify the associated risks of false results.
METHOD:
This study is based on a retrospective cytogenetic audit of CVS results (n = 44 727) generated by the STC + LTC analytic approach. False-negative risks related to true fetal mosaicism type IV, imprinting syndromes and maternal contamination in LTC were calculated.
RESULTS:
Compared with STC + LTC, QF-PCR + LTC approach is associated with a cumulative false-negative risk of ~1/3100-1/4400. Costs and reporting time of STC in a high-throughput cytogenetic lab are similar to a CE-IVD marked QF-PCR analysis.
CONCLUSIONS:
These results should be clearly highlighted in the pre-test counseling and extensively discussed with the couple prior to testing for informed consent.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity